Lexicon Pharmaceuticals, Inc. (LXRX) financial statements (2021 and earlier)

Company profile

Business Address 8800 TECHNOLOGY FOREST PLACE
THE WOODLANDS, TX 77381
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments152272160311347521339
Cash and cash equivalents12636806247203137
Short-term investments2623680249300318202
Receivables05765711
Inventory, net of allowances, customer advances and progress billings 452   
Inventory 452   
Other current assets55344105
Other undisclosed current assets      24
Total current assets:158338173322358532369
Noncurrent Assets
Property, plant and equipment014161819211
Intangible assets, net (including goodwill)45649596989898
Goodwill45454545454545
Intangible assets, net (excluding goodwill) 205052535353
Regulated entity, other noncurrent assets      3
Other noncurrent assets1200033
Other undisclosed noncurrent assets      (3)
Total noncurrent assets:4680111115118122102
TOTAL ASSETS:204418284437476655471
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities35543270854423
Accounts payable5121858532013
Accrued liabilities30421412322510
Debt121111416220
Deferred revenue and credits4063762
Other undisclosed current liabilities  3    
Total current liabilities:47653712416512345
Noncurrent Liabilities
Long-term debt and lease obligation, including: 12442328510488
Long-term debt, excluding current maturities 2342442328510488
Other undisclosed long-term debt and lease obligation (233)     
Liabilities, other than long-term debt116296814255
Deferred revenue and credits224910913
Deferred tax liabilities, net66191919
Other liabilities110011424
Other undisclosed noncurrent liabilities 23324    
Total noncurrent liabilities:1235274260154246142
Total liabilities:47301311384318369187
Stockholders' equity
Stockholders' equity attributable to parent156117(26)52157286284
Common stock0000001
Treasury stock, value(5)(4)(3)(2)(3)(3)(2)
Additional paid in capital1,5611,4621,4481,4361,4111,3981,390
Accumulated other comprehensive income (loss)(0)0(0)(0)(0)(0)(0)
Accumulated deficit(1,400)(1,341)(1,472)(1,381)(1,250)(1,109)(1,104)
Total stockholders' equity:156117(26)52157286284
TOTAL LIABILITIES AND EQUITY:204418284437476655471

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues2432263908313023
Revenue, net908313023
Cost of revenue
(Cost of Goods and Services Sold)
(2)(3)(2)(2)   
Gross profit:2231961888313023
Operating expenses(204)(181)(166)(227)(220)(129)(123)
Other undisclosed operating income135322   
Operating income (loss):(48)141(103)(137)(137)1(100)
Nonoperating income
(Other Nonoperating income)
3342212
Interest and debt expense(14)(21)(21)(7)(7)(7)(2)
Income (loss) from continuing operations before income taxes:(59)124(121)(142)(141)(5)(100)
Income tax benefit06 13  0
Income (loss) from continuing operations:(58)130(121)(129)(141)(5)(100)
Loss from discontinued operations(12)      
Income (loss) before gain (loss) on sale of properties:(71)130(121)(129)(141)(5)(100)
Other undisclosed net income120     
Net income (loss) available to common stockholders, basic:(59)130(121)(129)(141)(5)(100)
Dilutive securities, effect on basic earnings per share(59)135     
Net income (loss) available to common stockholders, diluted:(117)265(121)(129)(141)(5)(100)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(59)130(121)(129)(141)(5)(100)
Comprehensive income (loss):(59)130(121)(129)(141)(5)(100)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)00(0)0(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(59)130(120)(129)(141)(5)(100)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: